NHWD-870 / Ningbo Wenda Pharma 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NHWD-870 / Ningbo Wenda Pharma
ChiCTR2000040198: Phase I clinical study of NHWD-870 HCl in patients with advanced solid tumor or lymphoma

Not yet recruiting
1
30
 
NHWD-870 HCl
Department of Oncology, Xiangya Hospital, Central South University; Hunan Hengya Pharmaceutical Technology Co., Ltd., Hunan Hengya Pharmaceutical Technology Co., Ltd./Ningbo Wenda Pharmaceutical Technology Co., Ltd.
Advanced solid tumor or lymphoma
 
 
NCT06073938: Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

Recruiting
N/A
30
RoW
NHWD-870
Hunan Province Tumor Hospital
Advanced Solid Tumors or Lymphomas
12/23
06/24

Download Options